| NCT00782847 | Diabetic Nephropathy | Behavioral: DiaNe consultation and support program | DiaNe HCM GmbH|Roche Pharma Deutschland GmbH, Grenzach-Wyhlen, Germany|Institute for Medical Outcom Research GmbH, Loerrach, Germany | Phase 3 | 2004-07-01 | 2008-10-30 |
| NCT02494297 | Hirsutism|Seborrheic Alopecia|Severe Acne|Seborrhea | | Center for Epidemiology and Health Research, Germany|Bayer | | 2015-03-01 | 2016-11-02 |
| NCT00919022 | Prostate Cancer | Drug: Cyproterone Acetate (Androcur, BAY94-8367) | Bayer | | 2009-08-01 | 2012-10-30 |
| NCT02349399 | Acne Vulgaris | Drug: Cyproterone / Ethinylestradiol (Diane-35, BAY86-5264) and its Generics | Bayer | | 2015-05-01 | 2016-03-08 |
| NCT00005623 | Hot Flashes|Prostate Cancer | Drug: cyproterone acetate|Procedure: quality-of-life assessment | Barr Laboratories|National Cancer Institute (NCI) | Phase 3 | 1999-12-01 | 2013-03-25 |
| NCT00908674 | Prostate Cancer | Drug: Cyproterone acetate (Androcur) | Bayer | | 2008-06-01 | 2010-04-12 |
| NCT01752270 | Polycystic Ovary Syndrome | Drug: Diane-35 pretreatment|Drug: Diane-35 pretreatment | First Affiliated Hospital, Sun Yat-Sen University | Phase 4 | 2012-12-01 | 2012-12-16 |
| NCT01573377 | Polycystic Ovary Syndrome|Insulin Resistance | Drug: Metformin|Drug: Ethinylestradiol and Cyproterone Acetate | Chongqing Medical University | | 2012-02-01 | 2013-12-26 |
| NCT00752635 | Acne Vulgaris | Drug: Norgestimate-ethinyl estradiol; Cyproterone acetate-ethinyl estradiol | Johnson & Johnson Taiwan Ltd | Phase 4 | 2004-09-01 | 2011-05-18 |
| NCT02689843 | Polycystic Ovary Syndrome | Drug: Cyproterone compound + Spironolactone|Drug: Metformin|Drug: Pioglitazone | Shiraz University of Medical Sciences | Early Phase 1 | 2016-03-01 | 2016-08-02 |
| NCT00849082 | Prostate Cancer | Drug: cyproterone acetate|Drug: goserelin acetate|Radiation: radiation therapy | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 | 1987-05-01 | 2012-07-10 |
| NCT00363285 | Prostate Cancer | Biological: gonadotrophin releasing hormone|Drug: cyproterone acetate|Procedure: quality-of-life assessment | St. Bartholomew's Hospital|National Cancer Institute (NCI) | Phase 3 | 2003-01-01 | 2013-08-23 |
| NCT01011751 | Adenocarcinoma, Prostate | Drug: Cyproterone acetate|Drug: Medroxyprogesterone acetate|Drug: Venlafaxine|Drug: Leuprorelin|Drug: Flutamide|Drug: Placebo | Takeda | Phase 3 | 2004-04-01 | 2015-07-29 |
| NCT00955058 | Polycystic Ovary Syndrome | Drug: OCP | Shahid Beheshti University | Phase 2|Phase 3 | 2007-02-01 | 2009-09-01 |
| NCT03043924 | Polycystic Ovary Syndrome | Drug: Cyproterone Acetate + estradiol|Drug: Levonorgestrel, Ethinyl Estradiol 0.1-0.02Mg Oral Tablet | University Hospital, Lille|National Research Agency, France | | 2017-03-01 | 2017-02-02 |
| NCT02866786 | Polycystic Ovary Syndrome | Drug: Metformin|Drug: ethinyl estradiol and cyproterone acetate | S.C.B. Medical College and Hospital | Phase 4 | 2016-08-01 | 2016-08-31 |
| NCT02729545 | Polycystic Ovarian Syndrome | Other: acupuncture|Drug: Diane-35 | Beijing Hospital of Integrated Traditional Chinese and Western Medicine | Phase 2 | 2016-01-01 | 2016-03-31 |
| NCT02744131 | Polycystic Ovary Syndrome | Drug: Oral contraceptive pill combination of ethyl estradiol and Cyproterone acetate|Drug: Metformin 1500mgs per day | Kar Clinic & Hospital Pvt. Ltd.|All India Institute of Medical Sciences, New Delhi|Nova IVI Fertility, New Delhi|Dr Patil's Fertility & Endoscopy Clinic, Bangalore|Shreyas Hospital & Sushrut Assisted Conception Clinic, Kolhapur | | 2016-05-01 | 2016-08-30 |
| NCT01973816 | Endometriosis | Drug: Triptoreline 11.25 i.v.; Estradiol 0.5% percutaneous gel;|Procedure: rectal shaving; rectal disc excision; colorectal resection|Drug: Cyproterone acetate 50 mg; estradiol 0.5% percutaneous|Drug: Estradiol 0.5% percutaneous gel; Cyproterone acetate 50 mg oral | University Hospital, Rouen | Phase 3 | 2014-11-01 | 2016-08-16 |
